SCHEMBL19080106

SCHEMBL19080106

c1ccc2cc(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7c(c6)c6ccccc6c6c7oc7ccc8ccccc8c76)ccc5c4)c4ccccc34)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.41
CYP1B1 Q16678 1/20 0.41
ABCG2 Q9UNQ0 6/20 0.38
CYP1A2 P05177 3/20 0.37
AHR P35869 3/20 0.37
PAX8 Q06710 2/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
TDP1 Q9NUW8 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
ARSA P15289 1/20 0.34
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079995 0.97 CYP1A1 (0.40) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19080041 0.95 CYP1A1 (0.41) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19080005 0.93 CYP1A1 (0.40) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19080068 0.92 CYP1A1 (0.35) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19080088 0.92 CYP1A1 (0.38) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19080114 0.91 CYP1A1 (0.43) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19079953 0.90 ABCG2 (0.43) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL16067805 0.88 CYP1A1 (0.39) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19079998 0.88 CYP1A1 (0.41) CYP1A1CYP1B1ABCG2CYP1A2ARSA
SCHEMBL23502089 0.88 CYP1A1 (0.41) CYP1A1CYP1B1ABCG2CYP1A2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ABCG2 4758/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ABCG2 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.